Form 4 for SLXN Silexion Therapeutics Corp

Accepted 2025-12-31 00:00:00 ET · period of report 2025-02-09 · accession 0001178913-25-004143 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
D	2025-12-31	2025-02-09	SLXN	Peled Amnon	Dir	A - Grant	$0.00	+661	661	New	$0
D	2025-12-31	2025-02-09	SLXN	Peled Amnon	Dir	A - Grant	$0.00	+780	780	New	$0

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Ordinary Shares	2025-02-09	A	A	661	$0.00	661	D	—	—	(F1) Represents ordinary shares underlying RSUs granted to the Reporting Person by the Issuer, as consideration for the Reporting Person's service on the Issuer's board of directors. The shares subject to this award vest in full on the first anniversary of the grant date (i.e., on February 9, 2026), subject to the Reporting Person's continued service through such date. (F2) The number of ordinary shares reported in this row has been adjusted retroactively to reflect a 1-for-15 reverse share split effected by the Issuer on July 29, 2025.
2	Derivative	Stock Option (right to buy Ordinary Shares)	2025-02-09	A	A	780	$0.00	780	D	$18.90 · 2026-02-09 to 2035-02-09	780 Ordinary Shares	(F3) The number of options to purchase ordinary shares, and underlying ordinary shares, reported in this row have been adjusted downwards, and the exercise price of those options has been adjusted proportionately upwards, to reflect the 1-for-15 reverse share split effected by the Issuer on July 29, 2025. (F4) All of the stock options reported in this row vest (and become exercisable) on the first anniversary of the grant date (i.e., on February 9, 2026), subject to the Reporting Person's continued service through such date.